XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1Close
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 505 $ 401
Short-term investments 5 8
Accounts receivable, net 1,286 1,279
Inventories 1,244 1,450
Prepaid expenses and assets held for sale 59 261
Total current assets 3,099 3,399
Property, plant and equipment, net of accumulated depreciation of $3,451 and $3,428 2,291 2,370
Intangible assets, net of accumulated amortization of $311 and $299 1,275 1,303
Other non-current assets 556 570
Total assets 7,221 7,642 CloseClose
Current liabilities:    
Short-term borrowings 109 448
Accounts payable 606 778
Accrued liabilities and liabilities held for sale 515 546
Total current liabilities 1,230 1,772
Long-term debt 1,741 1,740
Other non-current liabilities 471 480
Total liabilities 3,442 3,992 CloseClose
Share-based payments subject to redemption 50 55
Redeemable non-controlling interests 7 43 Close
Ingredion stockholders’ equity:    
Preferred stock — authorized 25.0 shares — $0.01 par value, none issued 0 0
Common stock — authorized 200.0 shares — $0.01 par value, 77.8 shares issued at June 30, 2024 and December 31, 2023 1 1
Additional paid-in capital 1,141 1,146
Less: Treasury stock (common stock: 12.6 shares at June 30, 2024 and December 31, 2023) at cost (1,233) (1,207)
Accumulated other comprehensive loss (1,118) (1,056)
Retained earnings 4,914 4,654
Total Ingredion stockholders’ equity 3,705 3,538
Non-redeemable non-controlling interests 17 14
Total stockholders' equity 3,722 3,552 CloseClose
Total liabilities and stockholders' equity $ 7,221 $ 7,642